| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084256630 |
| P356 | DOI | 10.1245/S10434-017-5832-4 |
| P698 | PubMed publication ID | 28299508 |
| P50 | author | Giovanni Sgroi | Q64786032 |
| Fausto Petrelli | Q88397153 | ||
| Michele Ghidini | Q90625029 | ||
| Sandro Barni | Q114372608 | ||
| Gianluca Tomasello | Q115137173 | ||
| Rodolfo Passalacqua | Q115649339 | ||
| P2093 | author name string | Francesca Steccanella | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review | Q26865748 | ||
| Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 | ||
| Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis | Q27860511 | ||
| Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
| Comprehensive molecular characterization of gastric adenocarcinoma | Q28244985 | ||
| Helicobacter pylori infection and the development of gastric cancer | Q29615341 | ||
| Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base | Q30826217 | ||
| Ethnic disparities in gastric cancer incidence and survival in the USA: an updated analysis of 1992-2009 SEER data | Q30836835 | ||
| Clinical implications of metastatic lymph node ratio in gastric cancer | Q33303768 | ||
| Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group | Q33341367 | ||
| Application of Weibull model for survival of patients with gastric cancer | Q33787538 | ||
| The tumor-log odds of positive lymph nodes-metastasis staging system, a promising new staging system for gastric cancer after D2 resection in China | Q34163706 | ||
| Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system | Q34313918 | ||
| Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia | Q34546045 | ||
| Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. | Q34554455 | ||
| Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites | Q35981885 | ||
| Metastatic lymph node ratio as a prognostic factor in gastric cancer. | Q36005320 | ||
| IL-1B-511 Polymorphism Is Associated With Increased Risk of Certain Subtypes of Gastric Cancer in Chinese: A Case–Control Study | Q57272034 | ||
| Combined Evaluation of Expressions of Cyclin E and p53 Proteins as Prognostic Factors for Patients with Gastric Cancer | Q57312203 | ||
| Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery | Q59294455 | ||
| Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status | Q36013985 | ||
| Epstein-Barr virus infection and gastric cancer: a systematic review | Q36153008 | ||
| Comparison on Clinicopathological Features and Prognosis Between Esophagogastric Junctional Adenocarcinoma (Siewert II/III Types) and Distal Gastric Adenocarcinoma: Retrospective Cohort Study, a Single Institution, High Volume Experience in China | Q36153084 | ||
| A review of the genomics of gastric cancer | Q36449926 | ||
| Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival | Q36743301 | ||
| Effect of adjuvant chemoradiotherapy on overall survival of gastric cancer patients submitted to D2 lymphadenectomy. | Q36767808 | ||
| Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma | Q36999075 | ||
| Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China | Q37012387 | ||
| Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients | Q37135262 | ||
| Different lymph node staging systems in patients with gastric cancer from Korean: What is the best prognostic assessment tool? | Q37205096 | ||
| Docetaxel, Cisplatin, and 5-Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma | Q37429923 | ||
| Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease | Q37735582 | ||
| Validation of the updated 7th edition AJCC TNM staging criteria for gastric adenocarcinoma | Q37942517 | ||
| Evaluation of HER2-based biology in 1,006 cases of gastric cancer in a Japanese population | Q38083585 | ||
| Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma | Q38176226 | ||
| Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studies. | Q38641290 | ||
| Global patterns of cardia and non-cardia gastric cancer incidence in 2012. | Q38951159 | ||
| Postoperative chemotherapy in resected gastric cancer: results of a single center experience | Q40063515 | ||
| Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy | Q40121303 | ||
| Adenocarcinoma of the stomach: Review of 1,497 cases | Q40193432 | ||
| The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma. | Q40756645 | ||
| Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative. | Q41529022 | ||
| Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach | Q41538806 | ||
| Impact of postoperative infection on long-term survival after potentially curative resection for gastric cancer | Q44145195 | ||
| Clinicopathologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosis | Q44172938 | ||
| Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer | Q44530924 | ||
| Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach | Q45279301 | ||
| Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy. | Q45279369 | ||
| Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma | Q45376744 | ||
| The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. | Q46373510 | ||
| Long-term survivors of gastric cancer: a California population-based study | Q46381551 | ||
| Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). | Q46531277 | ||
| Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation | Q46564201 | ||
| The lymph node ratio as a prognostic factor for gastric cancer | Q46880177 | ||
| Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. | Q50909161 | ||
| Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. | Q51734991 | ||
| Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. | Q51772448 | ||
| The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona. | Q52841657 | ||
| Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis. | Q53128686 | ||
| Is gastric cancer different in Korea and the United States? Impact of tumor location on prognosis. | Q53292602 | ||
| Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection. | Q53314308 | ||
| TFF3 and HER2 expression and their correlation with survival in gastric cancer. | Q53667030 | ||
| Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. | Q54265509 | ||
| Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer. | Q54321983 | ||
| Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. | Q54483761 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 2655-2668 | |
| P577 | publication date | 2017-03-15 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies | |
| P478 | volume | 24 |
| Q91633191 | A Modified ypTNM Staging System-Development and External Validation of a Nomogram Predicting the Overall Survival of Gastric Cancer Patients Received Neoadjuvant Chemotherapy |
| Q49282014 | Analysis of survival and prognosis of 298 gastric adenocarcinoma patients with no distant metastasis |
| Q61797245 | Clinicopathologic characteristics of early gastric cancer according to specific intragastric location |
| Q91756528 | Comparison on Clinicopathological Features, Treatments and Prognosis between Proximal Gastric Cancer and Distal Gastric Cancer: A National Cancer Data Base Analysis |
| Q98665083 | Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer |
| Q92128435 | Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer |
| Q42332720 | Editorial on role of p53 in esophageal cancer from a meta-analysis of 16 studies by Fisher et al. |
| Q92636993 | Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis |
| Q47780456 | Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with Siewert type II/III early gastric cancer |
| Q64094461 | Outcome of head compared to body and tail pancreatic cancer: a systematic review and meta-analysis of 93 studies |
| Q92127339 | Racial/ethnic differences in survival among gastric cancer patients in california |
| Q50200654 | Survival Benefit of Additional Surgery After Non-curative Endoscopic Submucosal Dissection for Early Gastric Cancer: A Propensity Score Matching Analysis |
Search more.